China grants 1st patent to indigenously developed COVID-19 vaccine

China has granted the first invention patent to a Covid-19 vaccine co-developed by biopharmaceutical firm CanSino Biologics Inc in the country, which experts said demonstrates the vaccine's originality and creativity. According to a Global Times report, the vaccine is a recombinant adenovirus vaccine named Ad5-nCoV co-developed...